The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease.
Open accessAbstract
Apolipoprotein E (apoE) is critical in the modulation of cholesterol and phospholipid transport between cells of different types. Human apoE is a polymorphic protein with three common alleles, APO epsilon 2, APO epsilon 3, and APO epsilon 4. ApoE4 is associated with sporadic and late-onset familial Alzheimer disease (AD). Gene dose was shown to have an effect on risk of developing AD, age of onset, accumulation of senile plaques in the brain, and reduction of choline acetyltransferase (ChAT) activity in the hippocampus of AD subjects. To characterize the possible impact of the apoE4 allele on cholinergic markers in AD, we examined the effect of apoE4 allele copy number on pre- and postsynaptic markers of cholinergic activity. ApoE4 allele copy number showed an inverse relationship with residual brain ChAT activity and nicotinic receptor binding sites in both the hippocampal formation and the temporal cortex of AD subjects. AD cases lacking the apoE4 allele showed ChAT activities close or within age-matched normal control values. The effect of the apoE4 allele on cholinomimetic drug responsiveness was assessed next in a group (n = 40) of AD patients who completed a double-blind, 30-week clinical trial of the cholinesterase inhibitor tacrine. Results showed that > 80% of apoE4-negative AD patients showed marked improvement after 30 weeks as measured by the AD assessment scale (ADAS), whereas 60% of apoE4 carriers had ADAS scores that were worse compared to baseline. These results strongly support the concept that apoE4 plays a crucial role in the cholinergic dysfunction associated with AD and may be a prognostic indicator of poor response to therapy with acetylcholinesterase inhibitors in AD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
KARNOVSKY, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,367
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Apolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Self-citationKnapp, M. J. (1994) · JAMA · doi:10.1001/jama.271.13.985 · Cited by 1,004
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 755
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Apolipoprotein E in animal models of CNS injury and in alzheimer's disease
Poirier, J. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90156-2 · Cited by 639
Self-citationEvidence for a membrane defect in Alzheimer disease brain.
Nitsch, R. M., Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H., & Wurtman, R. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1671 · Cited by 536
The apolipoprotein ε4 allele in patients with Alzheimer's disease
Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993) · Annals of Neurology · doi:10.1002/ana.410340527 · Cited by 414
A Controlled Trial of Tacrine in Alzheimer's Disease
Farlow, M. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490180055026 · Cited by 398
Self-citationAstrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning
Poirier, J., Hess, M., May, P. C., & Finch, C. E. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90111-a · Cited by 380
Self-citationSvennerholm, L., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 330
Poirier, J., Baccichet, A., Dea, D., & Gauthier, S. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90456-p · Cited by 329
Self-citationAubert, I., Araujo, D. M., Cécyre, D., Robitaille, Y., Gauthier, S., & Quirion, R. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09752.x · Cited by 320
Self-citationDiedrich, J. F., Minnigan, H., Carp, R. I., Whitaker, J. N., Race, R., Frey, W., & Haase, A. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4759-4768.1991 · Cited by 296
Apolipoprotein E genotype and Alzheimer's disease
Noguchi, S., Murakami, K., Yamada, N., Payami, H., Kaye, J., Heston, L. L., Bird, T. D., & Schellenberg, G. D. (1993) · The Lancet · doi:10.1016/0140-6736(93)91728-5 · Cited by 285
Apolipoproteins in human cerebrospinal fluid.
Roheim, P. S., Carey, M., Forte, T., & Vega, G. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4646 · Cited by 282
Choline metabolism as a basis for the selective vulnerability of cholinergic neurons
Wurtman, R. J. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90351-8 · Cited by 246
Etienne, P., Robitaille, Y., Wood, P., Gauthier, S., Nair, N. P. V., & Quirion, R. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90142-9 · Cited by 213
Self-citationBertrand, P., Poirier, J., Oda, T., Finch, C. E., & Pasinetti, G. M. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00097-c · Cited by 210
Self-citationJones, O. T., & McNamee, M. G. (1988) · Biochemistry · doi:10.1021/bi00407a018 · Cited by 202
Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease
Hyman, B. T., Kromer, L. J., & van Hoesen, G. W. (1987) · Annals of Neurology · doi:10.1002/ana.410210307 · Cited by 177
Soininen, H., Kosunen, O., Helisalmi, S., Mannermaa, A., Paljärvi, L., Talasniemi, S., Ryynänen, M., & Riekkinen, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11343-6 · Cited by 162
Blusztajn, J. K., Liscovitch, M., & Richardson, U. I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.15.5474 · Cited by 159
Nalbantoglu, J. N., Gilfix, B. M., Bertrand, P., Robitaille, Y., Gauthier, S. G., Rosenblatt, D. S., & Poirier, J. (1994) · Annals of Neurology · doi:10.1002/ana.410360614 · Cited by 156
Self-citationBroeckhoven, C. V., Backhovens, H., Cruts, M., Martin, J. J., Crook, R., Houlden, H., & Hardy, J. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90385-9 · Cited by 126
Lewy bodies and response to tacrine in Alzheimer's disease
Levy, R., Eagger, S. A., Griffiths, M., Perry, E. K., Honavar, M., Dean, A. F., & Lantos, P. L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90966-0 · Cited by 120
Family Study of Platelet Membrane Fluidity in Alzheimer's Disease
Zubenko, G. S., Wusylko, M., Cohen, B. M., Boller, F., & Teply, I. (1987) · Science · doi:10.1126/science.3659926 · Cited by 114
Decreased myelin lipids in Alzheimer's disease and vascular dementia
Wallin, A., Gottfries, C. G., Karlsson, I., & Svennerholm, L. T. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03886.x · Cited by 101
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimerʼs disease
Blennow, K., Hesse, C., & Fredman, P. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00032 · Cited by 92
Poirier, J., Hess, M. A., May, P. C., & Finch, C. E. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90002-f · Cited by 90
Self-citationHippocampal membrane alteration in Alzheimer's disease
Zubenko, G. S. (1986) · Brain Research · doi:10.1016/0006-8993(86)91552-0 · Cited by 67
Intracellular membranes are more fluid in platelets of Alzheimer's disease patients
Piletz, J. E., Sarasua, M. M., Whitehouse, P. J., & Chotani, M. A. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90064-q · Cited by 43
Tacrine for senile dementia of Alzheimer's or Lewy body type
Wilcock, G., & Scott, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91933-x · Cited by 41
Seta, K., Nakamura, H., & Okuyama, T. (1990) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)89358-4 · Cited by 26
Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase
Dawson, R. M. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90689-7 · Cited by 24
Cited by
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
Evans, W. E., & Relling, M. V. (1999) · Science · doi:10.1126/science.286.5439.487 · Cited by 2,475
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70212-x · Cited by 881
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Medical and Ethical Consequences of the Human Genome Project
Collins, F. S. (1991) · The Journal of Clinical Ethics · doi:10.1086/jce199102411 · Cited by 666
Metadata
- Authors
- Poirier, J., Delisle, M. C., Quirion, R., Aubert, I., Farlow, M., Lahiri, D., Hui, S., Bertrand, P., Nalbantoglu, J., & Gilfix, B. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-12-19
- Volume
- 92
- Issue
- 26
- Pages
- 12260-12264
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2072150523
- Cited by
- 595
- References
- 39
- FWCI
- 21.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.